Rossari Biotech Limited (ROSSARI) — Cash Flow Quality Index
Rossari Biotech Limited (ROSSARI) has a Cash Flow Quality Index of 0.88x as of December 2023. Operating cash flow of Rs301.76 Million is below net income of Rs343.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Rossari Biotech Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Rossari Biotech Limited Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Rossari Biotech Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ROSSARI cash flow metrics.
Annual Cash Flow Quality Index for Rossari Biotech Limited (2017–2025)
Year-by-year earnings quality comparison for Rossari Biotech Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | Rs1.37 Billion | Rs1.36 Billion | ▲ +204.5% |
| 2024 | 0.33x | Rs432.55 Million | Rs1.31 Billion | ▼ -68.7% |
| 2023 | 1.06x | Rs1.52 Billion | Rs1.44 Billion | ▲ +390.5% |
| 2022 | 0.22x | Rs293.58 Million | Rs1.36 Billion | ▼ -52.0% |
| 2021 | 0.45x | Rs477.67 Million | Rs1.06 Billion | ▼ -27.9% |
| 2020 | 0.62x | Rs548.28 Million | Rs880.59 Million | ▼ -44.5% |
| 2019 | 1.12x | Rs711.77 Million | Rs633.92 Million | ▲ +64.6% |
| 2018 | 0.68x | Rs255.69 Million | Rs374.74 Million | ▲ +107.6% |
| 2017 | 0.33x | Rs46.95 Million | Rs142.85 Million | — |